Quarterly Results

SAMRAT PHARMACHEM LTD.

NSE : NABSE : 530125ISIN CODE : INE103E01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE383.457.9 (+2.1 %)
PREV CLOSE ( ) 375.55
OPEN PRICE ( ) 378.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2374
TODAY'S LOW / HIGH ( )375.00 383.75
52 WK LOW / HIGH ( ) 320594
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
616.74
797.45
575
691.81
Total Expenditure
615.61
795.13
567.09
696.69
PBIDT (Excl OI)
1.13
2.32
7.90
-4.88
Other Income
4.21
3
3.44
0.28
Operating Profit
5.34
5.31
11.35
-4.59
Interest
2.31
1.31
2.2
1.67
Exceptional Items
NA
NA
NA
NA
PBDT
3.03
4.00
9.15
-6.26
Depreciation
1.62
1.63
1.62
1.64
Profit Before Tax
1.41
2.37
7.53
-7.90
Tax
-2.03
4.25
1.42
-0.46
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
3.44
-1.87
6.11
-7.44
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
3.44
-1.87
6.11
-7.44
Equity Capital
30.9
30.9
30.9
30.9
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
1.11
-0.60
1.97
-2.41
Calculated EPS (Annualised)
4.45
-2.43
7.90
-9.64
No of Public Share Holdings
1586938
1586938
1586938
1586938
% of Public Share Holdings
51.36
51.36
51.36
51.36
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
0.18
0.29
1.37
-0.70
PBIDTM%
0.86
0.66
1.97
-0.66
PBDTM%
0.49
0.50
1.59
-0.90
PBTM%
0.22
0.29
1.30
-1.14
PATM%
0.55
-0.23
1.06
-1.07
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.